Esculentoside A suppresses Aβ_1–42-induced neuroinflammation by down-regulating MAPKs pathways in vivo

References

• Thies W, Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimer Dement. 2013;9:208–45.
   PubMed Web of Science ®Google Scholar
• Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013;381:2016–23.
   PubMed Web of Science ®Google Scholar
• Miller CA. Report from the World Alzheimer Congress 2000. Geriatr Nurs. 2000;21:274–5.
   PubMedGoogle Scholar
• Bettens K, Sleegers K, Van Broeckhoven C. Genetic insights in Alzheimer's disease. Lancet Neurol. 2013;12:92–104.
   PubMed Web of Science ®Google Scholar
• Azizi G, Mirshafiey A. The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis. Immunopharmacol Immunotoxicol. 2012;34:881–95.
   PubMed Web of Science ®Google Scholar
• Doens D, Fernandez PL. Microglia receptors and their implications in the response to amyloid beta for Alzheimer's disease pathogenesis. J Neuroinflammation. 2014;11:48.
   PubMed Web of Science ®Google Scholar
• Gu L, Guo Z. Alzheimer's Abeta42 and Abeta40 peptides form interlaced amyloid fibrils. J Neurochem. 2013;126:305–11.
   PubMed Web of Science ®Google Scholar
• Tang SS, Hong H, Chen L, Mei ZL, Ji MJ, Xiang GQ, et al. Involvement of cysteinyl leukotriene receptor 1 in Abeta1-42-induced neurotoxicity in vitro and in vivo. Neurobiol Aging. 2014;35:590–9.
   PubMed Web of Science ®Google Scholar
• Lyman M, Lloyd DG, Ji X, Vizcaychipi MP, Ma D. Neuroinflammation: the role and consequences. Neurosci Res. 2014;79C:1–12.
   Google Scholar
• Origlia N, Arancio O, Domenici L, Yan SS. MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE. Expert Rev Neurother. 2009;9:1635–45.
   PubMed Web of Science ®Google Scholar
• Sclip A, Tozzi A, Abaza A, Cardinetti D, Colombo I, Calabresi P, et al. c-JunN-terminnal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death Dis. 2014;5:e1019.
   PubMed Web of Science ®Google Scholar
• Munoz L, Ammit AJ. Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology. 2010;58:561–8.
   PubMed Web of Science ®Google Scholar
• Jahrling JB, Hernandez CM, Denner L, Dineley KT. PPARgamma recruitment to active ERK during memory consolidation is required for Alzheimer's disease-related cognitive enhancement. J Neurosci. 2014;34:4054–63.
   PubMed Web of Science ®Google Scholar
• Jun F, Yue ZQ, Bin WH, Wen JD, Hua YY. Effects of esculentoside A on turnour necrosis factor production by mice peritoneal macrophages. Mediators Inflamm. 1992;1:375–7.
   PubMedGoogle Scholar
• Ma H, Zhang X, Zhang X, Yang D, Meng L, Zhang Y, et al. The effect of esculentoside A on lupus nephritis-prone BXSB mice. Arch Med Sci. 2013;9:354–60.
   PubMed Web of Science ®Google Scholar
• Xiao ZY, Zheng QY, Jiang YY, Zhou B, Yin M, Wang HB, et al. Effects of esculentoside A on production of interleukin-1, 2, and prostaglandin E2. Acta Pharmacol Sin. 2004;25:817–21.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Su Y, Yang S, Yin L, Wang W, Yi Y, et al. Protective effect of esculentoside A on radiation-induced dermatitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006;65:882–9.
   PubMed Web of Science ®Google Scholar
• Zhong WT, Jiang LX, Wei JY, Qiao AN, Wei MM, Soromou LW, et al. Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice. J Surg Res. 2013;185:364–72.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang S, Yu L, Yang H, Tan R, Yin K, et al. TL-2 attenuates beta-amyloid induced neuronal apoptosis through the AKT/GSK-3beta/beta-catenin pathway. Int J Neuropsychopharmacol. 2014;17:1511–9.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang H, Yu L, Jin J, Qian L, Zhao H, et al. Oridonin attenuates Abeta1-42-induced neuroinflammation and inhibits NF-kappaB pathway. PloS One. 2014;9:e104745.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Yu LJ, Hui XC, Wu ZZ, Yin KL, Yang H, et al. Hydroxy-safflor yellow A attenuates Abeta(1)(-)(4)(2)-induced inflammation by modulating the JAK2/STAT3/NF-kappaB pathway. Brain Res. 2014;1563:72–80.
   PubMed Web of Science ®Google Scholar
• Zhao H, Wang SL, Qian L, Jin JL, Li H, Xu Y, et al. Diammonium glycyrrhizinate attenuates Abeta(1-42) -induced neuroinflammation and regulates MAPK and NF-kappaB pathways in vitro and in vivo. CNS Neurosci Ther. 2013;19:117–24.
   PubMed Web of Science ®Google Scholar
• Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal. 2012;2012:756357.
   PubMed Web of Science ®Google Scholar
• Thomas GM, Huganir RL. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci. 2004;5:173–83.
   PubMed Web of Science ®Google Scholar
• Kumagae Y, Zhang Y, Kim OJ, Miller CA. Human c-Jun N-terminal kinase expression and activation in the nervous system. Brain Res Mol Brain Res. 1999;67:10–17.
   PubMedGoogle Scholar
• Costello DA, Herron CE. The role of c-Jun N-terminal kinase in the A beta-mediated impairment of LTP and regulation of synaptic transmission in the hippocampus. Neuropharmacology. 2004;46:655–62.
   PubMed Web of Science ®Google Scholar
• Hensley K, Floyd RA, Zheng NY, Nael R, Robinson KA, Nguyen X, et al. p38 kinase is activated in the Alzheimer's disease brain. J Neurochem. 1999;72:2053–8.
   PubMed Web of Science ®Google Scholar
• Park SY, Park SJ, Park NJ, Joo WH, Lee SJ, Choi YW. alpha-Iso-cubebene exerts neuroprotective effects in amyloid beta stimulated microglia activation. Neurosci Lett. 2013;555:143–8.
   PubMed Web of Science ®Google Scholar
• Kim M, Li YX, Dewapriya P, Ryu B, Kim SK. Floridoside suppresses pro-inflammatory responses by blocking MAPK signaling in activated microglia. BMB Rep. 2013;46:398–403.
   PubMed Web of Science ®Google Scholar
• Ramin M, Azizi P, Motamedi F, Haghparast A, Khodagholi F. Inhibition of JNK phosphorylation reverses memory deficit induced by beta-amyloid (1-42) associated with decrease of apoptotic factors. Behav Brain Res. 2011;217:424–31.
   PubMed Web of Science ®Google Scholar
• Ashabi G, Ramin M, Azizi P, Taslimi Z, Alamdary SZ, Haghparast A, et al. ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1alpha levels in Abeta-injected rats. Behav Brain Res. 2012;232:165–73.
   PubMed Web of Science ®Google Scholar